Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michela Faggioni , Domenico G Della Rocca , Sanghamitra Mohanty , et al Added: 4 years ago
Heart failure with reduced ejection fraction (HFrEF) and AF share several predisposing risk factors and often coexist in the same population.1 Although AF can be a marker of worsening heart failure (HF), it can also be a main driver of disease progression. The presence of AF in patients with HFrEF is associated with an increased risk of stroke, re-hospitalisations and all-cause death.2 Therefore,… View more
Author(s): Afzal Sohaib Added: 1 year ago
ESC Congress 2022 — In this short and practice-focused review, Dr Afzal Sohaib,Electrophysiologist atBarts Health NHS Trust, shares his thoughts on the top 3 trials that will impact his practice. Trials covered in detail include: 00:18:eBRAVE-AF: eHealth-based Bavarian Alternative Detection of Atrial Fibrillation: A Randomized Controlled Trial 01:34:CAPLA: Catheter ablation for persistent… View more
Foreword

Article

Author(s): Andrew JS Coats , Giuseppe Rosano Added: 3 years ago
It is with great pleasure that we introduce to you, our readers, to volume 5, issue 2 of Cardiac Failure Review. This issue we are focusing on clinical syndromes and the impact and therapy of selected comorbidities commonly seen in the heart failure (HF) patient. Stolfo and Savarese take another look at the landmark trials of angiotensin-converting enzyme (ACE) inhibitors in HF from the… View more
Author(s): Sunil K Nadar , Muhammad Mujtaba Shaikh Added: 3 years ago
Dear Editor, We would like to thank García-Escobar and Ingelmo for their letter regarding our article on the use of biomarkers in routine clinical care for heart failure.1,2 It was with interest that we read their comments on the use of red cell volume distribution width (RDW) as another biomarker for use in the management of patients with heart failure. As mentioned in their letter, RDW is a… View more
Author(s): Milind Y Desai Added: 2 years ago
In this short summary interview, Dr Milind Y Desai (Cleveland Clinic, US) shares the findings from the VALOR-HCM trial (MyoKardia) (NCT04349072). This randomised, multicentre study was designed to assess the effect of mavacamten treatment on reducing the number of septal reduction therapy (SRT) procedures performed in subjects with symptomatic obstructive hypertrophic cardiomyopathy. Discussion… View more
Author(s): Saverio Iacopino Added: 5 years ago
Dr Saverio Iacopino discusses - 'Outcomes of Cryoballoon ablation in persistent and long -standing persistent atrial fibrillation - Real world evidence from 35 Italian Centers' at EHRA 2018. Filmed by Radcliffe Cardiology on site EHRA 2018. View more
Author(s): Saverio Iacopino Added: 5 years ago
Dr Saverio Iacopino discusses - 'Outcomes of Cryoballoon ablation in persistent and long-standing persistent atrial fibrillation - Real world evidence from 35 Italian Centers' at EHRA 2018 View more